Items tagged with Vaccines

4th Global Forum on TB Vaccines convened in Shanghai (post with simple image)

22 May 2015 - Shanghai, China -- Nearly 300 experts in tuberculosis (TB) and TB vaccine development from more than 30 countries around the world gathered in Shanghai in April for the 4th Global Forum on TB Vaccines to discuss the latest efforts and advances in TB vaccine development. The Forum, which was held April 21-24, is convened approximately every other year by the Stop TB Partnership’s Working Group on New Vaccines.

First participant in Impaact P1113 study vaccinated (post with simple image)

Great excitement reigned at the Worcester SATVI Field Site when the first baby participant in the IMPAACT P 1113 Study was vaccinated with the Aeras-404 candidate TB vaccine.

SLU’s vaccine center awarded $2.9 million to study new TB vaccine (post with simple image)

ST. LOUIS -- Saint Louis University's Center for Vaccine Development has received a $2.9 million award from the Bill & Melinda Gates Foundation to study a new tuberculosis vaccine.

HIV i-Base/TAG: 2015 Pipeline Report (post with simple image)

Latest annual review on HIV, HCV and TB drugs, diagnostics, vaccines, preventive technologies, research toward a cure, and immune-based and gene therapies in development.

2016 i-Base/TAG Pipeline Report (post with simple image)

Latest annual review on HIV and TB drugs, diagnostics, vaccines, preventive technologies, research toward a cure, and immune-based and gene therapies in development.

2017 TAG Pipeline Report (post with simple image)

TAG’s annual Pipeline Report: Promising new HIV, TB & HCV drugs and diagnostics.

Good Participatory Practice Guidelines for TB Vaccine Research (post with simple image)

Aeras releases a document providing systematic guidance on how to effectively engage stakeholders throughout the entire life cycle of TB vaccine research.

Page 10 of 10 · Total posts: 0

←First 9 10